Sernova Corp. (SVA.TO)
CAD 0.23
(0.0%)
CAD 0.23
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.13 CAD | -44.93% |
| 2022 | -0.09 CAD | -213.64% |
| 2021 | -0.03 CAD | -4.38% |
| 2020 | -0.03 CAD | -21.24% |
| 2019 | -0.02 CAD | 2.59% |
| 2018 | -0.02 CAD | -38.92% |
| 2017 | -0.02 CAD | 1.18% |
| 2016 | -0.02 CAD | 19.52% |
| 2015 | -0.02 CAD | 0.47% |
| 2014 | -0.02 CAD | -29.45% |
| 2013 | -0.02 CAD | 31.8% |
| 2012 | -0.02 CAD | -2.58% |
| 2011 | -0.02 CAD | 7.17% |
| 2010 | -0.03 CAD | -0.4% |
| 2009 | -0.02 CAD | 51.55% |
| 2008 | -0.05 CAD | 29.8% |
| 2007 | -0.07 CAD | -108.22% |
| 2006 | -0.04 CAD | -111.38% |
| 2005 | -0.02 CAD | 6.18% |
| 2004 | -0.02 CAD | 52.66% |
| 2003 | -0.04 CAD | 60.3% |
| 2002 | -0.09 CAD | 36.87% |
| 2001 | -0.15 CAD | -275.0% |
| 2000 | -0.04 CAD | -534.92% |
| 1999 | -0.01 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.03 CAD | 16.84% |
| 2024 Q3 | -0.02 CAD | 24.39% |
| 2024 Q2 | -0.03 CAD | -2.18% |
| 2023 Q4 | -0.04 CAD | -18.04% |
| 2023 Q2 | -0.03 CAD | -15.47% |
| 2023 Q3 | -0.03 CAD | -6.86% |
| 2023 Q1 | -0.03 CAD | 2.93% |
| 2023 FY | - CAD | -44.93% |
| 2022 FY | - CAD | -213.64% |
| 2022 Q3 | -0.02 CAD | -14.89% |
| 2022 Q1 | -0.02 CAD | -151.81% |
| 2022 Q2 | -0.02 CAD | 10.05% |
| 2022 Q4 | -0.03 CAD | -26.39% |
| 2021 FY | - CAD | -4.38% |
| 2021 Q1 | -0.01 CAD | -42.86% |
| 2021 Q3 | -0.01 CAD | 2.86% |
| 2021 Q4 | -0.01 CAD | -22.06% |
| 2021 Q2 | -0.01 CAD | 0.0% |
| 2020 Q2 | -0.01 CAD | -25.71% |
| 2020 Q1 | -0.01 CAD | 22.22% |
| 2020 Q4 | -0.00 CAD | 19.67% |
| 2020 Q3 | -0.01 CAD | 30.68% |
| 2020 FY | - CAD | -21.24% |
| 2019 Q3 | -0.01 CAD | -42.11% |
| 2019 Q1 | -0.00 CAD | 12.24% |
| 2019 FY | - CAD | 2.59% |
| 2019 Q4 | -0.01 CAD | -66.67% |
| 2019 Q2 | -0.00 CAD | 11.63% |
| 2018 Q1 | -0.00 CAD | 21.31% |
| 2018 FY | - CAD | -38.92% |
| 2018 Q4 | -0.00 CAD | 28.99% |
| 2018 Q3 | -0.01 CAD | -11.29% |
| 2018 Q2 | -0.01 CAD | -29.17% |
| 2017 Q2 | -0.00 CAD | -105.0% |
| 2017 Q1 | -0.00 CAD | -81.82% |
| 2017 FY | - CAD | 1.18% |
| 2017 Q4 | -0.01 CAD | -38.64% |
| 2017 Q3 | -0.00 CAD | -7.32% |
| 2016 Q3 | -0.01 CAD | -35.42% |
| 2016 Q4 | -0.00 CAD | 83.08% |
| 2016 FY | - CAD | 19.52% |
| 2016 Q1 | -0.00 CAD | 25.4% |
| 2016 Q2 | -0.00 CAD | -2.13% |
| 2015 Q4 | -0.01 CAD | -31.25% |
| 2015 Q2 | -0.01 CAD | -6.25% |
| 2015 Q3 | -0.00 CAD | 5.88% |
| 2015 Q1 | -0.00 CAD | 7.69% |
| 2015 FY | - CAD | 0.47% |
| 2014 Q3 | -0.01 CAD | 1.72% |
| 2014 FY | - CAD | -29.45% |
| 2014 Q4 | -0.01 CAD | 8.77% |
| 2014 Q2 | -0.01 CAD | -26.09% |
| 2014 Q1 | -0.00 CAD | -6.98% |
| 2013 Q4 | -0.00 CAD | -43.33% |
| 2013 Q2 | -0.00 CAD | 0.0% |
| 2013 Q1 | -0.00 CAD | 25.42% |
| 2013 FY | - CAD | 31.8% |
| 2013 Q3 | -0.00 CAD | 31.82% |
| 2012 FY | - CAD | -2.58% |
| 2012 Q1 | -0.01 CAD | -25.93% |
| 2012 Q4 | -0.01 CAD | -18.0% |
| 2012 Q2 | -0.01 CAD | 5.88% |
| 2012 Q3 | -0.01 CAD | 21.88% |
| 2011 Q1 | -0.01 CAD | -5.08% |
| 2011 FY | - CAD | 7.17% |
| 2011 Q4 | -0.01 CAD | -5.88% |
| 2011 Q3 | -0.01 CAD | 23.88% |
| 2011 Q2 | -0.01 CAD | -8.06% |
| 2010 FY | - CAD | -0.4% |
| 2010 Q2 | -0.01 CAD | 7.94% |
| 2010 Q3 | -0.01 CAD | -8.62% |
| 2010 Q4 | -0.01 CAD | 6.35% |
| 2010 Q1 | -0.01 CAD | 3.08% |
| 2009 Q2 | -0.01 CAD | -38.46% |
| 2009 FY | - CAD | 51.55% |
| 2009 Q3 | -0.01 CAD | 23.61% |
| 2009 Q4 | -0.01 CAD | -18.18% |
| 2009 Q1 | -0.01 CAD | 50.94% |
| 2008 Q1 | -0.01 CAD | 37.85% |
| 2008 Q4 | -0.01 CAD | -23.26% |
| 2008 FY | - CAD | 29.8% |
| 2008 Q3 | -0.01 CAD | 54.74% |
| 2008 Q2 | -0.02 CAD | -72.73% |
| 2007 Q4 | -0.02 CAD | 11.5% |
| 2007 Q3 | -0.02 CAD | 9.5% |
| 2007 Q1 | -0.01 CAD | -646.67% |
| 2007 Q2 | -0.02 CAD | -169.51% |
| 2007 FY | - CAD | -108.22% |
| 2006 Q4 | 0.00 CAD | 153.57% |
| 2006 FY | - CAD | -111.38% |
| 2006 Q2 | -0.04 CAD | -940.0% |
| 2006 Q3 | -0.00 CAD | 92.31% |
| 2006 Q1 | -0.00 CAD | 16.67% |
| 2005 Q1 | -0.00 CAD | -209.38% |
| 2005 Q2 | -0.01 CAD | -91.43% |
| 2005 Q3 | -0.00 CAD | 58.21% |
| 2005 Q4 | -0.00 CAD | -50.0% |
| 2005 FY | - CAD | 6.18% |
| 2004 FY | - CAD | 52.66% |
| 2004 Q4 | 0.00 CAD | 169.57% |
| 2004 Q3 | -0.00 CAD | 45.24% |
| 2004 Q2 | -0.01 CAD | 9.68% |
| 2004 Q1 | -0.01 CAD | -86.0% |
| 2003 Q1 | -0.02 CAD | -16.18% |
| 2003 Q3 | -0.00 CAD | 67.16% |
| 2003 FY | - CAD | 60.3% |
| 2003 Q4 | -0.01 CAD | -13.64% |
| 2003 Q2 | -0.01 CAD | 15.19% |
| 2002 FY | - CAD | 36.87% |
| 2002 Q3 | -0.02 CAD | 31.05% |
| 2002 Q2 | -0.03 CAD | -1.32% |
| 2002 Q1 | -0.03 CAD | 0.0% |
| 2002 Q4 | -0.01 CAD | 35.55% |
| 2001 FY | - CAD | -275.0% |
| 2000 FY | - CAD | -534.92% |
| 1999 FY | - CAD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Appili Therapeutics Inc. | -0.03 CAD | -316.667% |
| Eupraxia Pharmaceuticals Inc. | -1.58 CAD | 91.772% |
| Helix BioPharma Corp. | -0.21 CAD | 38.095% |
| Microbix Biosystems Inc. | -0.00 CAD | -43233.333% |
| Medicenna Therapeutics Corp. | -0.37 CAD | 64.865% |
| Satellos Bioscience Inc. | -0.18 CAD | 27.778% |
| Oncolytics Biotech Inc. | -0.41 CAD | 68.293% |